• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测老年透析患者死亡率的因素。

Factors predicting mortality in elderly patients on dialysis.

机构信息

Hospital Gregorio Marañón, Madrid, Spain.

出版信息

Nephron Clin Pract. 2010;115(1):c28-34. doi: 10.1159/000286347. Epub 2010 Feb 19.

DOI:10.1159/000286347
PMID:20173347
Abstract

UNLABELLED

Elderly patients are increasingly enrolled in dialysis programs and present a series of special characteristics due to their high morbidity and mortality.

OBJECTIVE

To describe the characteristics of incident dialysis patients aged >75 years, their comorbidities and their admissions, with a view to determining the factors that influence their course and mortality.

PATIENTS AND METHODS

The study included all patients aged >75 years who started dialysis in our center since January 2000. The mean duration of follow-up was 3.3 +/- 2.2 years. Data were collected on incident comorbidity, admissions and their causes. A total of 139 patients were included, with a mean age of 78.6 +/- 2.6 years (67.6% males, 33.8% diabetic and 7.9% on peritoneal dialysis). Three groups were established according to age: 75-79, 80-85 and >85 years. The most frequent comorbidities were chronic obstructive pulmonary disease (25.9%), ischemic heart disease (25.2%), heart failure (25.9%), neoplasms (23.7%), peripheral vascular disease (23.7%), cerebrovascular disease (18.7%) and arterial hypertension (81%). The Charlson index was calculated, not adjusted for age, and comorbidity tertiles were established.

RESULTS

During follow-up, the patients presented 0.82 +/- 0.99 admissions/patient/year, with a duration of 12.1 +/- 20.6 days/patient/year. The main causes of admission were infection (33%), vascular access problems (27%) and peripheral vascular events (14%). A total of 61 patients died (44%), and 4 underwent kidney transplantation (2.9%). The mean duration of follow-up of the transplanted patients was 3.6 +/- 1.8 years. The main causes of death were infection (32%), cardiovascular problems (28.3%) and neoplastic disease (11.3%). The global survival rate was 90, 82 and 53% after 1, 2 and 5 years, respectively. No significant differences in survival or annual admission rate were found in relation to age group and dialysis technique. In contrast, the annual admission rate and days of admission were directly correlated to the Charlson index (p = 0.009 and p = 0.032, respectively). No significant differences in the Charlson index were found between the patients on hemodialysis and those subjected to peritoneal dialysis. In the univariate model, the factors associated to mortality were diabetes, chronic obstructive pulmonary disease, heart failure and the Charlson index. In the multivariate model, only the Charlson index remained as an independent predictive factor (p = 0.006).

CONCLUSIONS

Unlike the general population, age does not influence mortality or admissions in elderly patients on dialysis. Incident comorbidity is the factor exerting the greatest influence upon mortality and admissions. Advanced age in itself should not be regarded as an excluding factor for starting dialysis.

摘要

目的

描述起始透析时年龄>75 岁的老年患者的特征、合并症及住院情况,以确定影响其病程和死亡率的因素。

方法

该研究纳入了自 2000 年 1 月以来在我院开始透析的所有年龄>75 岁的患者。平均随访时间为 3.3±2.2 年。收集了起始合并症、住院情况及其原因的数据。共纳入 139 例患者,平均年龄 78.6±2.6 岁(67.6%为男性,33.8%为糖尿病患者,7.9%接受腹膜透析)。根据年龄分为 3 组:75-79 岁、80-85 岁和>85 岁。最常见的合并症为慢性阻塞性肺疾病(25.9%)、缺血性心脏病(25.2%)、心力衰竭(25.9%)、肿瘤(23.7%)、外周血管疾病(23.7%)、脑血管疾病(18.7%)和高血压(81%)。计算了未调整年龄的 Charlson 指数,并建立了合并症三分位数。

结果

在随访期间,患者每年每例发生 0.82±0.99 次住院,住院天数为 12.1±20.6 天/例/年。住院的主要原因是感染(33%)、血管通路问题(27%)和外周血管事件(14%)。共有 61 例患者死亡(44%),4 例患者接受了肾移植(2.9%)。移植患者的平均随访时间为 3.6±1.8 年。死亡的主要原因是感染(32%)、心血管问题(28.3%)和肿瘤疾病(11.3%)。移植患者的 1、2 和 5 年总体生存率分别为 90%、82%和 53%。年龄组和透析技术与生存率或年住院率均无显著差异。相反,Charlson 指数与年住院率和住院天数呈正相关(p=0.009 和 p=0.032)。血液透析和腹膜透析患者的 Charlson 指数无显著差异。单因素模型中,与死亡率相关的因素为糖尿病、慢性阻塞性肺疾病、心力衰竭和 Charlson 指数。多因素模型中,只有 Charlson 指数是独立的预测因素(p=0.006)。

结论

与一般人群不同,在开始透析的老年患者中,年龄并不影响死亡率或住院率。起始合并症是影响死亡率和住院率的最大因素。高龄本身不应作为开始透析的排除因素。

相似文献

1
Factors predicting mortality in elderly patients on dialysis.预测老年透析患者死亡率的因素。
Nephron Clin Pract. 2010;115(1):c28-34. doi: 10.1159/000286347. Epub 2010 Feb 19.
2
[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].[威尼托地区透析与移植登记处:2006 - 2007年报告]
G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56.
3
Elderly patients with chronic kidney disease: outcomes after 5 years of follow-up.老年慢性肾脏病患者:5 年随访后的结局。
Nefrologia. 2012 May 14;32(3):300-5. doi: 10.3265/Nefrologia.pre2012.Jan.10994. Epub 2012 Feb 28.
4
[Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].[近年来加那利群岛新入透析患者的中期生存分析:当前腹膜透析与血液透析的比较]
Nefrologia. 2011;31(2):174-84. doi: 10.3265/Nefrologia.pre2011.Jan.10743.
5
Peritoneal dialysis and kidney transplant. A two-way ticket in an integrated renal replacement therapy model.腹膜透析和肾移植。在综合肾脏替代治疗模式中的一张双向票。
Nefrologia. 2011;31(4):441-8. doi: 10.3265/Nefrologia.pre2011.May.10898.
6
A Mediterranean age-comorbidity prognostic index for survival in dialysis populations.一种用于透析人群生存的地中海年龄合并症预后指数。
J Nephrol. 2007 Nov-Dec;20(6):696-702.
7
Charlson Comorbidity Index is a predictor of outcomes in incident hemodialysis patients and correlates with phase angle and hospitalization.查尔森合并症指数是新发血液透析患者预后的一个预测指标,且与相位角和住院情况相关。
Int J Artif Organs. 2004 Apr;27(4):330-6. doi: 10.1177/039139880402700409.
8
[Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].[西班牙血液透析患者的心血管风险:患病率、管理及目标结果(MAR研究)]
Nefrologia. 2005;25(3):297-306.
9
Comparable outcome of acute unplanned peritoneal dialysis and haemodialysis.急性非计划性腹膜透析与血液透析的可比结局。
Nephrol Dial Transplant. 2012 Jan;27(1):375-80. doi: 10.1093/ndt/gfr262. Epub 2011 May 28.
10
Survival of elderly dialysis patients is predicted by both patient and practice characteristics.老年透析患者的生存率受到患者和实践特征的双重预测。
Nephrol Dial Transplant. 2012 Sep;27(9):3581-7. doi: 10.1093/ndt/gfs096. Epub 2012 May 7.

引用本文的文献

1
Peritoneal dialysis versus haemodialysis for people commencing dialysis.腹膜透析与血液透析治疗开始透析的患者。
Cochrane Database Syst Rev. 2024 Jun 20;6(6):CD013800. doi: 10.1002/14651858.CD013800.pub2.
2
In-hospital mortality among incident hemodialysis older patients in Peru.秘鲁新血液透析老年患者的住院死亡率。
Int Health. 2020 Feb 12;12(2):142-147. doi: 10.1093/inthealth/ihz037.
3
Subjective Global Assessment-Dialysis Malnutrition Score and cardiovascular risk in hemodialysis patients: an observational cohort study.
主观全面评估-透析营养不良评分与血液透析患者心血管风险:一项观察性队列研究。
J Nephrol. 2018 Oct;31(5):757-765. doi: 10.1007/s40620-018-0505-3. Epub 2018 Jun 23.
4
Survival analysis of conservative vs. dialysis treatment of elderly patients with CKD stage 5.老年慢性肾脏病5期患者保守治疗与透析治疗的生存分析
PLoS One. 2017 Jul 24;12(7):e0181345. doi: 10.1371/journal.pone.0181345. eCollection 2017.
5
More Use of Peritoneal Dialysis Gives Significant Savings: A Systematic Review and Health Economic Decision Model.更多地使用腹膜透析可带来显著的成本节约:一项系统评价与卫生经济决策模型
J Clin Med Res. 2017 Feb;9(2):104-116. doi: 10.14740/jocmr2817w. Epub 2016 Dec 31.
6
Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study.老年血液透析人群的发病率、死亡率及生活质量:老年研究结果
Clin Kidney J. 2016 Dec;9(6):839-848. doi: 10.1093/ckj/sfw087. Epub 2016 Sep 26.
7
A Randomized Controlled Trial of a Mobile Clinical Decision Aid to Improve Access to Kidney Transplantation: iChoose Kidney.一项关于移动临床决策辅助工具以改善肾移植可及性的随机对照试验:iChoose Kidney
Kidney Int Rep. 2016 May;1(1):34-42. doi: 10.1016/j.ekir.2016.04.001. Epub 2016 Apr 20.
8
Survival of elderly dialysis patients is not dependent on modality or "older" age.老年透析患者的生存率并不取决于透析方式或年龄“较大”。
Indian J Nephrol. 2016 Jan-Feb;26(1):23-6. doi: 10.4103/0971-4065.157801.
9
iChoose Kidney: A Clinical Decision Aid for Kidney Transplantation Versus Dialysis Treatment.我选择肾脏:肾移植与透析治疗的临床决策辅助工具
Transplantation. 2016 Mar;100(3):630-9. doi: 10.1097/TP.0000000000001019.
10
How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center.在过去30年里腹膜透析发生了怎样的变化:维罗纳透析中心的经验
BMC Nephrol. 2015 Apr 14;16:53. doi: 10.1186/s12882-015-0051-3.